Company News

PharmaLex Group strengthens biosimilar expertise PCI Clinical Services welcomes Jamie Weishaar to North American Clinical Sales Team ASLAN Pharmaceuticals CEO Dr Carl Firth appointed to IAC singapore Intelligent Fingerprinting strengthens R&D team appointing Alan Pang New National Distribution Manager for Hi-line Industries West appoints Alessandra Rispoli Senior Director of Operations GEA appoints Martine Snels as new member to the Executive Board Oxford BioDynamics appoint Paul Stockdale CFO Agility Health appointments new Board Director Susan Hyatt Bernhard Kernen named CFO of Raumedic iTeos Therapeutics appoints Mohamed Ragab VP of Corporate Development Mission Therapeutics appoints Scientific Advisory Board Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat serious diseases including... Medherant appoints Sally Waterman COO and Angus Hone CFO Pretium announces new senior vice president of sales, marketing Mark Howell brings more than 20 years of packaging sales and business development experience Verona Pharma appoints Vice President of Regulatory Affairs IGEM Therapeutics appoints Dr Tim Wilson CEO

Trending Articles

  1. Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
  2. Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
  3. CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
  4. Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
  5. Hovione appoints Stefan Doboczky as Chief Executive Officer Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all